Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
SG&A Expense Growth
1.59%
Fiscal year · Period ending:
LCTX SG&A Expense Growth
Latest reported1.59%period ending
Latest reported1.59%period ending
LCTX FY SG&A Growth (YoY) (0.00% → 1.59%)
Latest values, visible window
High-resolution chart · PNG
LCTX sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 1.5904% | |
| 5.0225% | |
| -23.1296% | |
| 23.5888% | |
| 16.961% | |
| -35.2045% | |
| -2.8108% | |
| 24.114% | |
| -29.9163% | |
| -2.4302% | |
| 65.948% | |
| 12.838% | |
| 50.1072% | |
| 10.9569% | |
| 65.6175% | |
| 127.7622% | |
| -5.4867% | |
| 101.457% | |
| -12.8043% | |
| 6.8555% | |
| -5.9585% | |
| 17.7408% | |
| -4.3581% | |
| -32.793% | |
| 10.192% | |
| -6.1559% | |
| 170.9557% | |
| -41.6667% | |
| -42.8571% | |
| 162.5% | |
| -11.1111% | |
| 12.5% | |
| 100% | |
| 0% |